A series of neutral technetium-99m beta-diketonate radiopharmaceutical
s containing the Tc = N group has been prepared in which the substitue
nt of the beta-diketone ligand is varied to cause chemical changes in
the resultant complexes. Analyses by TLC, HPLC, and paper electrophore
sis show that the complexes are neutral, lipidsoluble tracers. Their i
n-vitro properties, evaluated by means of octanol-water and cyclohexan
e-water partition coefficients and protein binding determination, show
a high lipophilic character which may give them potential as a brain
imaging agent.